These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 19845755

  • 1. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC, Quéreux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dréno B.
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [Abstract] [Full Text] [Related]

  • 2. About the cutaneous targets of bexarotene in CTCL patients.
    Knol AC, Quéreux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dréno B.
    Exp Dermatol; 2010 Aug; 19(8):e299-301. PubMed ID: 19845753
    [Abstract] [Full Text] [Related]

  • 3. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG.
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [Abstract] [Full Text] [Related]

  • 4. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B.
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [Abstract] [Full Text] [Related]

  • 5. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
    Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J, Quick S, Stumpf C, Hartmann M, Enk A, Ruzicka T, Krammer PH, Suri-Payer E, Kuhn A.
    Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
    [Abstract] [Full Text] [Related]

  • 6. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
    Abbott RA, Whittaker SJ, Morris SL, Russell-Jones R, Hung T, Bashir SJ, Scarisbrick JJ.
    Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
    [Abstract] [Full Text] [Related]

  • 7. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [Abstract] [Full Text] [Related]

  • 8. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.
    Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin SF.
    Exp Dermatol; 2007 Jan; 16(1):13-21. PubMed ID: 17181632
    [Abstract] [Full Text] [Related]

  • 9. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973
    [Abstract] [Full Text] [Related]

  • 10. Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.
    Martin AG.
    J Drugs Dermatol; 2003 Apr 27; 2(2):155-67. PubMed ID: 12852367
    [Abstract] [Full Text] [Related]

  • 11. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
    Chen WC, Chiang BL, Liu HE, Leu SJ, Lee YL.
    J Dermatol Sci; 2008 Aug 27; 51(2):121-30. PubMed ID: 18440785
    [Abstract] [Full Text] [Related]

  • 12. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY.
    Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692
    [Abstract] [Full Text] [Related]

  • 13. Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma.
    Ballanger F, Nguyen JM, Khammari A, Dréno B.
    Dermatology; 2010 Apr 05; 220(4):370-5. PubMed ID: 20484880
    [Abstract] [Full Text] [Related]

  • 14. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
    Marzano AV, Vezzoli P, Fanoni D, Venegoni L, Berti E.
    J Am Acad Dermatol; 2009 Aug 05; 61(2):348-55. PubMed ID: 19615546
    [Abstract] [Full Text] [Related]

  • 15. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A.
    Transplantation; 2007 Jul 15; 84(1):31-9. PubMed ID: 17627234
    [Abstract] [Full Text] [Related]

  • 16. The optimal use of bexarotene in cutaneous T-cell lymphoma.
    Gniadecki R, Assaf C, Bagot M, Dummer R, Duvic M, Knobler R, Ranki A, Schwandt P, Whittaker S.
    Br J Dermatol; 2007 Sep 15; 157(3):433-40. PubMed ID: 17553039
    [Abstract] [Full Text] [Related]

  • 17. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.
    Arthritis Rheum; 2008 Mar 15; 58(3):801-12. PubMed ID: 18311820
    [Abstract] [Full Text] [Related]

  • 18. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM, Pérez-García V, Marín-Alberca G, Peris-Pertusa A, Benito JM, Marco FM, Zubcoff JJ, Navarro-Blasco FJ.
    Autoimmunity; 2009 Mar 15; 42(8):636-45. PubMed ID: 19886735
    [Abstract] [Full Text] [Related]

  • 19. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.
    Transpl Immunol; 2008 Apr 15; 19(1):69-73. PubMed ID: 18346640
    [Abstract] [Full Text] [Related]

  • 20. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A, Zhang B, Qu Y, Zhang A, Sun C, Zhang L, Liu J, Zeng C, Zhao Y.
    Transpl Immunol; 2009 Mar 15; 20(4):253-60. PubMed ID: 19146957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.